203 related articles for article (PubMed ID: 18060334)
21. Antiobesity drugs in early pregnancy and congenital malformations in the offspring.
Källén BA
Obes Res Clin Pract; 2014; 8(6):e571-6. PubMed ID: 25434912
[TBL] [Abstract][Full Text] [Related]
22. Effect of antiobesity medications in patients with type 2 diabetes mellitus.
Choussein S; Makri AA; Frangos CC; Petridou ET; Daskalopoulou SS
Diabetes Obes Metab; 2009 Jul; 11(7):641-64. PubMed ID: 19236442
[TBL] [Abstract][Full Text] [Related]
23. Rimonabant for the treatment of overweight and obese people.
Burch J; McKenna C; Palmer S; Norman G; Glanville J; Sculpher M; Woolacott N
Health Technol Assess; 2009 Oct; 13 Suppl 3():13-22. PubMed ID: 19846024
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemia.
Florentin M; Kostapanos MS; Nakou ES; Elisaf M; Liberopoulos EN
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):274-82. PubMed ID: 19724023
[TBL] [Abstract][Full Text] [Related]
25. [Overweight patient has tried many times to lose weight. What helps against stubborn fat padding?].
Wirth A
MMW Fortschr Med; 2003 Mar; 145(10):16. PubMed ID: 12688021
[No Abstract] [Full Text] [Related]
26. Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk.
Caterson ID; Finer N
Asia Pac J Clin Nutr; 2006; 15 Suppl():55-62. PubMed ID: 16928662
[TBL] [Abstract][Full Text] [Related]
27. [The endocannabinoid system and treatment of obesity].
Aronsen L
Tidsskr Nor Laegeforen; 2008 Feb; 128(5):570-1. PubMed ID: 18311201
[TBL] [Abstract][Full Text] [Related]
28. Obesity drug therapy.
Baretić M
Minerva Endocrinol; 2013 Sep; 38(3):245-54. PubMed ID: 24126545
[TBL] [Abstract][Full Text] [Related]
29. Add-on combination and maintenance treatment: case series of five obese patients with different eating behavior.
Anghelescu I; Klawe C; Szegedi A
J Clin Psychopharmacol; 2002 Oct; 22(5):521-4. PubMed ID: 12352278
[TBL] [Abstract][Full Text] [Related]
30. Rimonabant: new drug. Obesity: loss of a few kilos, many questions.
Prescrire Int; 2006 Aug; 15(84):123-6. PubMed ID: 16977739
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity.
Gokcel A; Gumurdulu Y; Karakose H; Melek Ertorer E; Tanaci N; BascilTutuncu N; Guvener N
Diabetes Obes Metab; 2002 Jan; 4(1):49-55. PubMed ID: 11874442
[TBL] [Abstract][Full Text] [Related]
32. Drug treatments for obesity: orlistat, sibutramine, and rimonabant.
Padwal RS; Majumdar SR
Lancet; 2007 Jan; 369(9555):71-7. PubMed ID: 17208644
[TBL] [Abstract][Full Text] [Related]
33. Obesity and cardiovascular physiology: impact of some pharmacological agents.
Chaput JP; Bérubé-Parent S; Tremblay A
Curr Vasc Pharmacol; 2005 Apr; 3(2):185-93. PubMed ID: 15853638
[TBL] [Abstract][Full Text] [Related]
34. [A drug help in reducing? Risk profile decides whether and how].
Hauner H
MMW Fortschr Med; 2003 May; 145(21):60. PubMed ID: 12845877
[No Abstract] [Full Text] [Related]
35. Long-term pharmacotherapy for obesity.
Klein S
Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
[TBL] [Abstract][Full Text] [Related]
36. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
Richter WO
MMW Fortschr Med; 1999 Dec; 141(49-50):32-6. PubMed ID: 10726144
[TBL] [Abstract][Full Text] [Related]
37. Pharmacotherapy for obesity.
Neff LM; Aronne LJ
Curr Atheroscler Rep; 2007 Dec; 9(6):454-62. PubMed ID: 18377785
[TBL] [Abstract][Full Text] [Related]
38. Pharmacotherapy of obesity.
Finer N
Best Pract Res Clin Endocrinol Metab; 2002 Dec; 16(4):717-42. PubMed ID: 12468417
[TBL] [Abstract][Full Text] [Related]
39. NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
Erondu N; Addy C; Lu K; Mallick M; Musser B; Gantz I; Proietto J; Astrup A; Toubro S; Rissannen AM; Tonstad S; Haynes WG; Gottesdiener KM; Kaufman KD; Amatruda JM; Heymsfield SB
Obesity (Silver Spring); 2007 Aug; 15(8):2027-42. PubMed ID: 17712121
[TBL] [Abstract][Full Text] [Related]
40. Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents.
García Díaz E; Martín Folgueras T
Nutr Hosp; 2011; 26(3):451-7. PubMed ID: 21892560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]